Is Opioid Agonist Treatment Associated With Reduced Risk of Overall and Cause-Specific Mortality in Opioid-Dependent People? - 18/11/21
Doi : 10.1016/j.annemergmed.2021.07.119
Le texte complet de cet article est disponible en PDF.
Plan
| Editor’s Note: This is a clinical synopsis, a regular feature of the Annals’ Systematic Review Snapshot (SRS) series. The source for this systematic review snapshot is: Santo T Jr, Clark B, Hickman M, et al. Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence: a systematic review and meta-analysis. JAMA Psychiatry. 2021. https://doi.org/10.1001/jamapsychiatry.2021.0976 |
|
| This review does not reflect the views or opinions of the US Government, Department of Defense or its components, US Army, US Air Force, Brooke Army Medical Center, or the SAUSHEC EM Residency Program. |
|
| Jestin N. Carlson, MD, MS, Alan Jones, MD, and Michael Gottlieb, MD, serve as editors of the SRS series. Dr. Carlson was the supervising editor on this article. Dr. Gottlieb did not participate in the editorial review or decision to publish this article. |
© 2021
American College of Emergency Physicians. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 78 - N° 6
P. 776-778 - décembre 2021 Retour au numéro
Article précédent
- Addressing Opioid Use Disorder in the Emergency Department: Should We Have a Metric of Success?
- Jeanmarie Perrone, Lewis S. Nelson
- Comparison of Nebulized Ketamine at Three Different Dosing Regimens for Treating Painful Conditions in the Emergency Department: A Prospective, Randomized, Double-Blind Clinical Trial
- Daniel Dove, Catsim Fassassi, Ashley Davis, Jefferson Drapkin, Mahlaqa Butt, Rukhsana Hossain, Sarah Kabariti, Antonios Likourezos, Ankit Gohel, Patrizia Favale, Michael Silver, John Marshall, Sergey Motov
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?